About
Hakan Goker is Managing Director and head of the Biotechnology team at M Ventures, the strategic venture capital fund of Merck KGaA, where he oversees healthcare and life sciences investments. With 15 years of venture investing experience across Atlas Venture, Aescap Venture, and M Ventures since 2013, Goker has been involved in the formation and management of multiple companies including Artios Pharma, Orphazyme, f-Star, Bicycle Therapeutics, Nimbus Discovery, Storm Therapeutics, and Ribometrix. He is responsible for directing M Ventures' portfolio strategy from its Amsterdam headquarters, with additional offices in the US and Israel, focusing on early-stage investments and company creation in transformational biotechnology.
Contact· published on Hakan's own website
Experience
- M VenturesManaging Directorcurrent2021 — present
- M VenturesVice President, Head of Healthcare Investments2020 — 2021Amsterdam, North Holland, Netherlands
- M VenturesExecutive Investment Director2019 — 2020The Randstad, Netherlands
- M VenturesSenior Investment Director2013 — 2018
- NRG TherapeuticsBoard Observercurrent2025 — present
- TRIMTECH Therapeutics LimitedBoard Membercurrent2025 — present
- ReproNovoBoard Membercurrent2024 — present
- NouscomBoard Membercurrent2023 — present
- Artios Pharma LtdBoard Membercurrent2016 — presentGreater Cambridge Area
- iOncturaBoard Member (ex- founding chairman)current2020 — presentGeneva, Switzerland
- iOncturaChairman Of The Board2017 — 2020Switzerland
- RibometrixBoard Membercurrent2018 — presentRaleigh-Durham-Chapel Hill Area
- STORM Therapeutics LimitedBoard Membercurrent2015 — presentGreater Cambridge Area
- Asceneuron SABoard Director and previous acting CBO &Observercurrent2013 — presentLausanne, Vaud, Switzerland
- BioPartnerAdvisory Board Membercurrent2013 — present
- Anglo Nordic Biotechnology and Medtech ConferenceCommittee Chairmancurrent2008 — presentUK and Nordic Regions
- ActitheraChairman2021 — 2025Boston, Massachusetts, United States
- Forendo Pharma LtdBoard Director2014 — 2021Finland
- SynAffix BVBoard Director2013 — 2021Netherlands
- Macrophage PharmaBoard Member2017 — 2021United Kingdom
- European Private Equity and Venture Capital Association (EVCA)Venture Capital Platform Council Member2015 — 2020Brussels Metropolitan Area
- TocopherxBoard Director2015 — 2020Greater Boston
- Raze Therapeutics, Inc.Board Director2015 — 2019
- Progyny, Inc.Board Director2015 — 2018San Francisco Bay Area/ NYC
- BioeuraxManaging Director2013Netherlands
- OrphazymeBoard member2011 — 2013Copenhagen Metropolitan Area
- f-star, Protaffin, to-BBBBoard Observer2010 — 2013UK, Austria, Netherlands
- Aescap VenturePartner2010 — 2013The Randstad, Netherlands
- Atlas VentureSenior Associate2006 — 2010
- f-Star, Protaffin, Nitec, Lumavita, Xytis, Bicycle TherapeuticsBoard Observer2007 — 2010Various Europe and US
- Institute of Cancer ResearchPostdoctoral Fellow2000 — 2006
Skills & more
Board GovernanceBoard OperationVenture Capital48Lifesciences8Investments4Portfolio Management3Fundraising1Business Development3Healthcare2Scientific Analysis1Recruiting1Biotechnology36
+12 more
Drug DiscoveryMolecular BiologyTechnology TransferClinical DevelopmentCorporate DevelopmentStart-upsenterpreneurshipBusiness StrategyPharmaceutical IndustryStrategyEntrepreneurshipR&DFrom Hakan's professional profile.
Colleagues at M Ventures
Network1
Investors connected to Hakan in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Hakan Goker?
- Hakan Goker is Managing Director and head of the Biotechnology team at M Ventures, the strategic venture capital fund of Merck KGaA, where he oversees healthcare and life sciences investments. With 15 years of venture investing experience across Atlas Venture, Aescap Venture, and M Ventures since 2013, Goker has been involved in the formation and management of multiple companies including Artios Pharma, Orphazyme, f-Star, Bicycle Therapeutics, Nimbus Discovery, Storm Therapeutics, and Ribometrix. He is responsible for directing M Ventures' portfolio strategy from its Amsterdam headquarters, with additional offices in the US and Israel, focusing on early-stage investments and company creation in transformational biotechnology.
- Where does Hakan Goker work?
- Hakan Goker is Managing Director at M Ventures.
- Where did Hakan Goker go to school?
- Hakan Goker studied at University of London (PhD, Molecular Genetics); Association of International Cancer Research (AICR) Scholar (Doctor of Philosophy (PhD)); Chevening/ Commonwealth Scholar.
Same school
Also attended University of London130
Sandra SchwarzerInvestor at Index VenturesAnneleen PeetersNon-executive Director at Capricorn Venture PartnersKarim GillaniGeneral Partner at Luge CapitalRoxanneCompliance Officer at Hummingbird VenturesRakesh MurriaCOO at Nauta CapitalJos WhiteGeneral Partner at Notion Capital
+ 124 more
Shared employers
Also worked at M Ventures34
Roel BulthuisInvestor at SynconaArturo UrriosPartner at Ysios CapitalTherese LiechtensteinPartner at 4BIO CapitalDave RosenbergInvestor at ACVC PartnersMauricio RestrepoAssociate at IGNIADr. Nadine GeiserPrincipal at World Fund
_edited_edited.jpg)
+ 28 more
Also worked at TRIMTECH Therapeutics Limited9
Damian Crowtherex-AstraZeneca at PICUS CAPITALMichael AnsteyPartner at Cambridge Innovation CapitalJeffrey MoorePresident at MC Healthcare VenturesAmer RamzanManaging Partner at Promentum Equity PartnersGeorgia FrostSenior Associate at Dementia DiscoveryGeorgia FrostVice President at Dementia Discovery Fund
+ 3 more
